TNM Classification of Malignant Tumours, 8th Edition - Softcover

TNM Classification of Malignant Tumours, Eighth Edition provides the latest, internationally agreed standards to describe and categorize cancer stages. Published in affiliation with the Union for International Cancer Control (UICC), this authoritative pocket-sized guide contains important updated organ-specific classifications that oncologists and other professionals who manage patients with cancer need to accurately classify tumours for staging, prognosis and treatment.

• Arranged by anatomical region, this authoritative pocket-sized guide delivers updates in staging in head and neck carcinomas, carcinomas of the thyroid, oesophagus, stomach, anal canal, lung, pleura, skin, ovary, prostate, penis and adrenal cortex, as well as neuroendocrine tumours, and bone and soft tissue sarcomas.
• There are new classifications for p16 positive oropharyngeal carcinomas, carcinomas of the thymus, neuroendocrine tumours of the pancreas, and sarcomas of the spine and pelvis and soft tissue sarcomas of the head and neck, thoracic and abdominal visceral and retroperitoneum.
• To facilitate the collection of stage data for cancer surveillance in low and middle income countries, there are new sections on Essential TNM in colon and rectum, breast, cervix and prostate carcinomas and simplified Stage for Paediatric Cancer.
• Clear and carefully templated chapters covering anatomical subsite, regional lymph nodes, TNM clinical classification, pathological classification, histopathological grading, stage grouping and the newer prognostic grouping (where relevant) allow rapid referral to key information.

An updated format and colour presentation further enhance the usability of this indispensable resource for all medical, surgical and radiation oncologists, anatomic and surgical pathologists, oncology nurses and physician extenders, international cancer care centres and governmental organizations and NGOs dedicated to cancer control.

James D. Brierley, BSc, MB, FRCP, FRCR, FRCPC Professor, Department of Radiation Oncology, Princess Margaret Cancer Centre and the University of Toronto, Canada Dr Brierley trained in Clinical Oncology in the UK and developed his interest in cancer staging and surveillance when moving to Canada and has been involved in cancer surveillance, locally, nationally and internationally. He is Co-Chair of the UICC TNM Prognostic Factors Project. He has co-edited the TNM Supplement 4th edition (Wiley 2012) and the UICC Manual of Clinical Oncology (Wiley 2015). Mary K. Gospodarowicz MD, FRCPC, FRCR (Hon) Medical Director, Princess Margaret Cancer Centre, University Health Network; Regional Vice-President of Cancer Care Ontario for Toronto South; Toronto, Ontario, Canada Dr Gospodarowicz is the Past-President of UICC. She has a long-standing interest in cancer classification with an emphasis on staging and prognostic factors and she has been involved in the UICC TNM Project for many years. Her interests include the application of modern information and communication technologies in cancer control. Dr Gospodarowicz was coeditor of the 7th edition of the TNM Classification of Malignant Tumours (Wiley 2009) and editor of the 2nd and 3rd editions of the UICC Prognostic Factors in Cancer (Wiley 2001, 2006). Christian Wittekind MD Professor of Pathology, Chairman Institute of Pathology, University of Leipzig, Germany Dr Wittekind been involved in cancer staging and tumour classifications for over 20 years. He is a member of the UICC TNM Core Committee, Head of the German Speaking TNM-Komittee, and personally responds to all the questions to the UICC TNM helpdesk. He was the coeditor of the 5th , 6th and 7th edition of the TNM classification of Malignant Tumours (Wiley 1997, 2002, 2009) editor of the 2nd, 3rd, and 4th edition of the TNM Supplement (Wiley 2001, 2003 and 2012) and editor of the 6th edition of the TNM Atlas (Wiley 2014).